Quinagolide
Systematic (IUPAC) name | |
---|---|
N,N-diethyl-N'-[(3S,4aS,10aR)-6-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-3-yl]sulfamide | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status |
|
Routes of administration | Oral |
Identifiers | |
CAS Number | 87056-78-8 |
ATC code | G02CB04 |
PubChem | CID 55645 |
ChemSpider | 2343034 |
UNII | 80Q9QWN15M |
KEGG | D07217 |
ChEMBL | CHEMBL290962 |
Chemical data | |
Formula | C20H33N3O3S |
Molar mass | 395.56 g/mol |
| |
(what is this?) (verify) |
Quinagolide (Norprolac) is a selective, D2 receptor agonist that is used for the treatment of elevated levels of prolactin.[1]
See also
References
- ↑ Antonella Di Sarno, Maria Luisa Landi, Paolo Marzullo, Carolina Di Somma, Rosario Pivonello, Gaetana Cerbone, Gaetano Lombardi, Annamaria Colao (July 2000). "The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas". Clinical Endocrinology 53 (1): 53–60. doi:10.1046/j.1365-2265.2000.01016.x. PMID 10931080.
|
|
This article is issued from Wikipedia - version of the Saturday, November 01, 2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.